Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Affordability is key to providing accessible healthcare for Bharat.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Subscribe To Our Newsletter & Stay Updated
